Document:

Exhibit

Exhibit 10.2 
AMENDMENT NO. 2 TO FORBEARANCE AGREEMENT

This Amendment No. 2 to the Forbearance Agreement (this “Second Amendment”) is entered into as of April 24, 2019 by and between Monitronics International, Inc., a Texas corporation (the “Borrower”), each other Loan Party to the Credit Agreement, Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and certain Lenders party hereto (collectively, the “Parties”).
RECITALS
A.    On April 1, 2019, the Parties entered into that certain Forbearance Agreement (as amended by Amendment No. 1, dated April 12, 2019, between the Parties, the “Forbearance Agreement”), under which the Required Lenders agreed to temporarily forbear on enforcement of the Specified Defaults, subject to the terms and conditions contained in the Forbearance Agreement.
B.    The Forbearance Agreement contains a milestone that provides that no later than 5:00 p.m. (New York Time) on April 24, 2019 (the “RSA Deadline”), the Borrower shall have entered into a restructuring support agreement acceptable to holders of at least 50% of the outstanding Term B-2 Loans, in their sole discretion (the “RSA Milestone”).  In the event that the RSA Milestone is not satisfied by the RSA Deadline, the Forbearance Period terminates pursuant to the terms of the Forbearance Agreement.  The Forbearance Agreement further provided that, if the RSA Milestone is not satisfied by the RSA Deadline, the Borrower shall, commencing on April 24, 2019, pay interest on the principal amount of all outstanding Obligations under the Credit Agreement at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable Law (the “Default Interest Provision”).
C.    The Parties hereby desire to further extend the RSA Deadline to no later than 5:00 p.m. (New York Time) on April 30, 2019, while making clear that the Default Interest Provision is triggered as of April 24, 2019 in accordance with the Forbearance Agreement. 
Now, therefore, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the Administrative Agent, the Borrower, and the undersigned Lenders hereby acknowledge, agree and consent to the following:
1.Defined Terms.  Except as defined herein, capitalized terms used herein shall have the meanings, if any, assigned to such terms in the Forbearance Agreement.

2.Interpretation.  The rules of interpretation set forth in Section 1.02 of the Credit Agreement shall be applicable to this Second Amendment and are incorporated herein by this reference.

3.Amendments.  

(a)    Section 7(c) of the Forbearance Agreement is replaced in its entirety and further amended as follows:

“(c)    Commencing on April 24, 2019, the Borrower shall pay interest on the principal amount of all outstanding Obligations under the Credit Agreement at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable Law.  For the avoidance of doubt, in the event that the milestone in Section 8(b) is not satisfied, the obligation to pay interest on the terms set forth in the prior sentence shall survive the Forbearance Termination Date and shall continue to apply until such date as the Borrower shall have entered into a restructuring support agreement acceptable to holders of at least 50% of the outstanding Term B-2 Loans, in their sole discretion.”

(b)    Section 8(b) of the Forbearance Agreement is replaced in its entirety and further amended as follows:

“(b)    No later than 5:00 p.m. (New York Time) on April 30, 2019, the Borrower shall have entered into a restructuring support agreement acceptable to holders of at least 50% of the outstanding Term B-2 Loans, in their sole discretion.” 
4.    Other Terms.  Except as expressly set forth herein, all other terms of the Forbearance Agreement shall remain in full force and effect, and nothing in this Second Amendment shall be construed as modifying or amending any such terms unless otherwise expressly provided herein.

5.    Conditions Precedent to Effectiveness.  This Second Amendment shall become effective on the date (the “Second Amendment Effective Date”) upon which each of the conditions precedent set forth below have been satisfied:

(a)the Administrative Agent (or its counsel) shall have received a counterpart of this Second Amendment signed by each of the Borrower, the Administrative Agent and the Required Lenders.

(b)after giving effect to the forbearance under the Forbearance Agreement, the representations and warranties of the Borrower contained in Article V of the Credit Agreement or any other Loan Document are true and correct in all material respects (or with respect to representations and warranties qualified by materiality, in all respects) on and as of the Second Amendment Effective Date, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date in all material respects (or with respect to representations and warranties qualified by materiality, in all respects), except that the representations and warranties contained in Sections 5.05(a) and (b) of the Credit Agreement shall be deemed to refer to the most recent statements furnished pursuant to Sections 6.01(a) and (b) of the Credit Agreement, respectively.

6.    Counterparts.  This Second Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.  Delivery of an executed counterpart of a signature page of this Second Amendment by telecopy or other electronic imaging means (including “.pdf”) shall be effective as delivery of a manually executed counterpart of this Second Amendment.

[signature pages follow]

IN WITNESS WHEREOF, the parties have executed this Second Amendment as of the date and year first above written.
	
			
	 
	MONITRONICS INTERNATIONAL, INC.

	 
	 
	 

	 
	 
	 

	 
	By:
	/s/ William E. Niles

	 
	 
	Name: William E. Niles

	 
	 
	Title: Executive Vice President and Secretary

[Signature page to Amendment No. 2 to Forbearance Agreement]

[BANK OF AMERICA, N.A.]

[Signature page to Amendment No. 2 to Forbearance Agreement]

[CONSENTING LENDER]

[Signature page to Amendment No. 2 to Forbearance Agreement]Exhibit 10.1

    

    

    

    

    

    

    

    

    EMPLOYMENT AGREEMENT

    EMPLOYMENT AGREEMENT, dated as of May 12, 2019 (this “Agreement”), by and between Emerald Expositions, LLC, a Delaware limited liability company (the “Company”),
        and Sally Shankland (the “Executive”) (each of the Executive and the Company, a “Party,”

        and collectively, the “Parties”) and, solely for purposes of Section 2.3, Emerald Expositions Events, Inc., a Delaware corporation (“Parent”).

    WHEREAS, the Company desires to employ the Executive as Chief Executive Officer of the Company and wishes to acquire and
        be assured of the Executive’s services on the terms and conditions hereinafter set forth; and

    

    

    WHEREAS, the Executive desires to be employed by the Company as Chief Executive Officer and to perform and to serve the
        Company on the terms and conditions hereinafter set forth.

    

    

    NOW, THEREFORE, in consideration of the mutual covenants contained herein and other valid
        consideration, the sufficiency of which is acknowledged, the Parties hereto agree as follows:

    Section 1.             Employment.

    1.1. Term.  Subject to
        Section 3 hereof, the Company agrees to employ the Executive, and the Executive agrees to be employed by the Company, in each case pursuant to this Agreement, for a period commencing on June 1, 2019 (the “Effective Date”) and ending on the third anniversary of the Effective Date (the “Initial Term”); provided, however, that the period of the Executive’s employment
        pursuant to this Agreement shall be automatically extended for successive one-year periods thereafter (each, a “Renewal Term”), in each case unless either
        Party hereto provides the other Party hereto with written notice that such period shall not be so extended at least 30 days in advance of the expiration of the Initial Term or the then-current Renewal Term, as applicable (the Initial Term and any
        Renewal Term, collectively, the “Term”).  Each additional one-year Renewal Term shall be added to the end of the next scheduled expiration date of the
        Initial Term or Renewal Term, as applicable, as of the first day after the last date on which notice may be given pursuant to the preceding sentence.  The Executive’s period of employment pursuant to this Agreement shall hereinafter be referred to
        as the “Employment Period.”

    1.2. Duties.  During the Employment Period, the
        Executive shall serve as the Company’s Chief Executive Officer and in such other positions as an officer or director of the Company and such Affiliates of the
        Company as the Executive and the board of directors of Parent (the “Board”) shall mutually agree from time to time, and shall report directly to the Board.  In the Executive’s position as Chief Executive Officer, the Executive shall
        perform such duties, functions and responsibilities during the Employment Period as are commensurate with such position, as reasonably and lawfully directed by the Board.  During the Employment Period, the Executive shall continue to serve as a
        member of the Board.  The Executive’s principal place of employment shall be the Company’s offices in New York, New York.

    1.3. Exclusivity.  During the Employment Period, the Executive shall devote substantially
        all of the Executive’s business time and attention to the business and affairs of the Company, shall faithfully serve the Company, and shall conform to and comply with the lawful and reasonable directions and instructions given to the Executive by
        the Board, consistent with Section 1.2 hereof.  During the Employment Period, the Executive shall use the Executive’s best efforts to promote and serve the interests of the Company and shall not engage in any other business activity, whether or not
        such activity shall be engaged in for pecuniary profit; provided that the Executive may (a) serve any civic, charitable, educational or professional
        organization for up to one hour per month and (b) manage the Executive’s personal investments, in each case so long as any such activities do not (X) violate the terms of this Agreement (including Section 4) or (Y) interfere with the Executive’s
        duties and responsibilities to the Company.

    Section 2.             Compensation.

    2.1. Salary.  As compensation for the performance of the Executive’s services hereunder,
        during the Employment Period, the Company shall pay to the Executive a salary at an annual rate of $650,000, payable in accordance with the Company’s standard
        payroll policies (the “Base Salary”).

    2.2. Annual Bonus.  For each calendar year ending during the Employment Period, the
        Executive shall be eligible to receive an annual bonus (the “Annual Bonus”) to be based upon Company performance and other criteria for each such calendar
        year as determined by the Board.  The Executive’s target Annual Bonus opportunity for each calendar year that ends during the Employment Period shall be $700,000 (the “Target

            Annual Bonus Opportunity”).  For calendar year 2019, in no event shall the Annual Bonus be less than $490,000.  The amount of the Annual Bonus actually paid shall depend on the extent to which the performance goals, set annually by
        the Board, are achieved or exceeded.  The Annual Bonus shall be paid in the calendar year following the calendar year in respect of which it is earned at the same time as the Company normally pays bonuses to other senior executives; provided, that, if the Executive’s employment hereunder is terminated prior to the Annual Bonus payment date (a) by the Company for Cause or (b) by the Executive
        voluntarily without Good Reason and not for death or Disability, the Annual Bonus shall not be payable.

    2.3. Equity.  The Executive shall be provided the following equity incentive interests
        and/or rights to purchase equity interests in the Parent:

          (a) Initial Equity Grant.  On or as soon as practicable following the Effective Date,
        Parent shall grant to the Executive a combination of restricted stock units (“RSUs”) and an option to purchase common stock of Parent (an “Option”), pursuant to Parent’s 2017 Omnibus Equity Plan (the “Equity Plan”). 

        The RSUs and Option shall have an aggregate value of $1,000,000 on the date of grant, with the Option valued based on its Black-Scholes value and RSUs valued based on the present market value of the underlying common stock of Parent, in each case
        as of the date of grant.  For future years, the Executive will be eligible to receive equity grants commensurate with her position, as determined by the Compensation Committee of Parent.

          (b) One-Time Performance Equity Grant.  On or as soon as practicable following the
        Effective Date, Executive shall receive an additional one-time performance based share award with vesting linked to the Company’s achievement of certain stock prices during the Employment Period, pursuant to the Equity Plan and a performance based
        share award agreement, substantially in the form attached hereto as Exhibit A.

    2.4. Employee Benefits.  During the Employment Period, the Executive shall be eligible to
        participate in such health and other group insurance and other employee benefit plans and programs of the Company as in effect from time to time on the same basis as other senior executives of the Company.

    2.5. Vacation.  During the Employment Period, the Executive shall be entitled to an unlimited number of vacation days, pursuant to the Company’s MyTime policy.

    2.6. Business Expenses.  The Company shall pay or reimburse the Executive, upon
        presentation of documentation, for all commercially reasonable business out-of-pocket expenses that the Executive incurs during the Employment Period in performing the Executive’s duties under this Agreement in accordance with the expense
        reimbursement policy of the Company as approved by the Board (or a committee thereof), as in effect from time to time.  To the extent that any travel requires a flight approximately two hours or longer, Executive shall be permitted to fly business
        class.  Notwithstanding anything herein to the contrary or otherwise, except to the extent any expense or reimbursement described in this Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A of the Internal
        Revenue Code of 1986, as amended, and the regulations and guidance thereunder (“Section 409A”), any expense or reimbursement described in this Agreement
        shall meet the following requirements: (a) the amount of expenses eligible for reimbursement provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement to the Executive in any other calendar
        year; (b) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred; (c) the right to
        payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit; and (d) the reimbursements shall be made pursuant to objectively determinable and nondiscretionary Company policies and procedures
        regarding such reimbursement of expenses.

    2.7. Executive Housing.  Promptly following receipt of appropriate supporting documentation
        (if applicable), during the Employment Period, the Company shall either reimburse the Executive, pay on the Executive’s behalf, or make available to the Executive a fully furnished corporate apartment or reasonably equivalent lodging in the New
        York City, New York area.  In addition, Company shall reimburse the Executive for parking and other expenses such as utilities, up to $1,500 per month.  If at any time or from time to time the reimbursement or payment of the expenses to be
        reimbursed or paid to the Executive pursuant to this Section 2.7 are properly characterized under the Code (as defined below) or other applicable state or local law as federal, state and/or local taxable income to the Executive, the Company shall
        fully “gross-up” the Executive to compensate her for any such income (or other) tax obligation as well as any federal, state or local income (or other) tax due on the gross-up payment itself.

    2.8. Legal Fees.  The Company shall reimburse the Executive up to $15,000 for reasonable,
        documented legal fees and related expenses incurred in connection with the drafting, negotiation and execution of this Agreement.

    Section 3.             Employment Termination.

    3.1. Termination of Employment.  The Company may terminate the Executive’s employment
        hereunder for any reason during the Term, and the Executive may voluntarily terminate the Executive’s employment hereunder for any reason during the Term at any time upon not less than 15 days’ notice to the Company (the date on which the
        Executive’s employment terminates for any reason is herein referred to as the “Termination Date”).  Upon the termination of the Executive’s employment with
        the Company for any reason, the Executive shall be entitled to (a) payment of any Base Salary earned but unpaid through the Termination Date, (b) earned but unpaid Annual Bonus for calendar years completed prior to the Termination Date (payable in
        the ordinary course pursuant to Section 2.2), (c) vested benefits (if any) in accordance with the applicable terms of applicable Company arrangements and (d) any unreimbursed expenses in accordance with Sections 2.6 and 2.7 hereof (collectively,
        the “Accrued Amounts”) provided, however, that if the Executive’s employment hereunder is terminated (X) by the Company for Cause or (Y) by the Executive voluntarily without Good Reason and not for death or Disability,
        then any Annual Bonus earned pursuant to Section 2.2 in respect of a prior calendar year, but not yet paid or due to be paid, shall be forfeited.

    3.2. Certain Terminations.

          (a) Termination by the Company other than for Cause, Death or Disability; Termination by the
            Executive for Good Reason.  If the Executive’s employment is terminated (X) by the Company other than for Cause, death or Disability or (Y) by the Executive for Good Reason, in addition to the Accrued Amounts, the Executive shall be
        entitled to: (i) a payment equal to one times the sum of the Executive’s Base Salary at the rate in effect immediately prior to the Termination Date and the Annual Bonus actually paid to the Executive for the previous calendar year (or the Target
        Annual Bonus Opportunity if the Termination Date occurs prior to the payment of the first Annual Bonus) (the “Severance Amount”); and (ii) subject to the
        timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) and the Executive’s copayment
        of premiums associated with such coverage consistent with amounts paid by the Executive during the year in which the Termination Date occurs, the Company shall reimburse the Executive, on a monthly basis, for the excess costs of continued health
        benefits for herself and her covered dependents for the twelve-month period following the Termination Date, or such earlier date on which COBRA coverage for the Executive and her covered dependents terminates in accordance with COBRA (“Medical Benefit Continuation”).

    The Company’s obligations to pay the Severance Amount and to provide Medical Benefit Continuation
        shall be conditioned upon (i) the Executive’s continued compliance with the Executive’s obligations under Section 4 of this Agreement and (ii) Executive executing and delivering to the Company a general release in the form attached hereto as Exhibit B (the “Release”) and the Release becoming irrevocable within
        30 days following the Termination Date (the date that the Release becomes irrevocable, the “Release Effective Date”).  Payments of the Severance Amount and
        the Medical Benefit Continuation will be paid or commence to be paid on the first payroll date of the Company following the Release Effective Date; provided,
        that, if the 30-day period referred to in the preceding sentence spans two calendar years, payments shall in all cases be paid or commence to be paid on the
        first payroll date in the second calendar year; provided, further,
        that, the first payment will include any installments that would have been paid prior thereto but for this sentence.

    If the Executive is not permitted to continue participation in the Company’s medical insurance plan
        pursuant to the terms of such plan or pursuant to a determination by the Company’s insurance providers or such continued participation in any plan would result in the imposition of an excise tax on the Company pursuant to Section 4980D of the
        Internal Revenue Code of 1986, as amended (the “Code”), the Company shall use reasonable efforts to obtain individual insurance policies providing medical
        benefits to the Executive during the Medical Benefits Continuation period, but shall be required to pay for such policies only an amount equal to the amount the Company would have paid had the Executive continued participation in the Company’s
        medical plans; provided that, if such coverage cannot be obtained, the Company shall pay to the Executive monthly during the Medical Benefit Continuation
        period an amount equal to the amount the Company would have paid had the Executive continued participation in the Company’s medical plan.

          (b) Termination by Death or Disability.  If the Executive’s employment is terminated by
        reason of the Executive’s death or Disability, the Company shall pay the Executive (or the Executive’s heirs upon a termination by death) a pro-rata bonus for the year of termination, equal to the Annual Bonus the Executive would have been entitled
        to receive had the Executive’s employment not been terminated, based on the actual performance of the Company for the full year, multiplied by a fraction, the numerator of which is the number of days the Executive is employed by the Company during
        the applicable year prior to and including the Termination Date and the denominator of which is 365, payable at the time when annual bonuses are paid generally.

          (c) Definitions.  For purposes of Section 3, the following terms have the following
        meanings:

       (1) “Cause” shall mean the Executive’s having engaged in any of the following: (A) willful
        misconduct or gross negligence in the performance of any of the Executive’s duties to the Company, which, if capable of being cured, is not cured to the reasonable satisfaction of the Board within 30 days after the Executive receives from the Board
        written notice of such willful misconduct or gross negligence; (B) intentional failure or refusal to perform reasonably assigned duties by the Board or to cooperate with an internal investigation being conducted by or at the direction of the Board,
        which is not cured to the reasonable satisfaction of the Board within 30 days after the Executive receives from the Board written notice of such failure or refusal; (C) any indictment for, conviction of, or plea of guilty or nolo contendere to, (1)
        any felony (other than motor vehicle offenses the effect of which do not materially affect the performance of the Executive’s duties) or (2) any crime (whether or not a felony) involving fraud, theft, breach of trust or similar acts, whether of the
        United States or any state thereof or any similar foreign law to which the Executive may be subject; (D) any willful failure to comply with any written rules, regulations, policies or procedures of the Company which, if not complied with, would
        reasonably be expected to have a material adverse effect on the business or financial condition of the Company, which in the case of a failure that is capable of being cured, is not cured to the reasonable satisfaction of the Board within 30 days
        after the Executive receives from the Company written notice of such failure or (E) abuse of alcohol or another controlled substance. If the Company terminates the Executive’s employment for Cause, the Company shall provide written notice to the
        Executive of that fact on or before the termination of employment.  However, if, within 60 days following the termination, the Company first discovers facts that would have established “Cause” for termination under clauses (C) or (E) of the
        foregoing definition, and those facts were not known by the Company at the time of the termination, then the Company may provide Executive with written notice, including the facts establishing that the purported “Cause” was not known at the time of
        the termination, in which case the Executive’s termination of employment will be considered a for Cause termination under this Agreement, and Executive shall be required to immediately return to the Company all amounts previously paid or provided
        to the Executive pursuant to Section 3.2(a), and the Company shall have the right to cease to pay or provide any future amounts pursuant to Section 3.2(a).

       (2) “Disability” shall mean the Executive is entitled to and has begun to receive
        long-term disability benefits under the long-term disability plan of the Company in which the Executive participates, or, if there is no such plan, the Executive’s inability, due to physical or mental illness, to perform the essential functions of
        the Executive’s job, with or without a reasonable accommodation, for 180 days out of any 270 day consecutive day period.

       (3) “Good Reason” shall mean one of the following has occurred: (A) a material breach by
        the Company of any of the covenants in this Agreement; (B) any material reduction in the Executive’s Base Salary or bonus opportunity; (C) the relocation of the Executive’s principal place of employment that would increase the Executive’s one-way
        commute by more than 50 miles; or (D) any material and adverse change in the Executive’s position, title or status or any change in the Executive’s job duties, authority or responsibilities to those of lesser status.  A termination of employment by
        the Executive for Good Reason shall be effectuated by giving the Company written notice of the termination, setting forth the conduct of the Company that constitutes Good Reason, within 30 days of the first date on which the Executive has knowledge of such conduct.  The Executive shall further provide the Company at least 30 days following the date on which such notice is provided
        to cure such conduct.  Failing such cure, a termination of employment by the Executive for Good Reason shall be effective on the day following the expiration of such cure period.

         (d) Section 409A.  If the Executive is a “specified employee” for purposes of Section
        409A, to the extent the Severance Amount required to be made pursuant to Section 3.2 hereof constitutes “non-qualified deferred compensation” for purposes of Section 409A, payment thereof shall be delayed until the day after the first to occur of
        (i) the day which is six months from the Termination Date and (ii) the date of the Executive’s death, with any delayed amounts being paid in a lump sum on such date and any remaining payments being made in the normal course.  For purposes of this
        Agreement, the terms “terminate,” “terminated” and “termination” mean a termination of the Executive’s employment that constitutes a “separation from service” within the meaning of the default rules under Section 409A.  For purposes of Section
        409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments.

    3.3. Exclusive Remedy.  The foregoing payments upon termination of the Executive’s
        employment shall constitute the exclusive severance payments and benefits due the Executive upon a termination of the Executive’s employment.

    3.4. Resignation from All Positions.  Upon the termination of the Executive’s employment
        with the Company for any reason, the Executive shall resign, as of the Termination Date, from all positions the Executive then holds as an officer, director, employee and member of the boards of directors (and any committee thereof) of the Company
        and its Affiliates.  The Executive shall be required to execute such writings as are required to effectuate the foregoing.

    3.5. Cooperation.  Following the termination of the Executive’s employment with the Company
        for any reason, upon reasonable request from the Company, the Executive shall respond and provide information with respect to matters in which Executive has knowledge as a result of her services to the Company and its subsidiaries, and will provide
        reasonable assistance to the Company in defense of any claims that may be made against the Company, and will assist the Company in the prosecution of any claims that may be made by the Company, to the extent that such claims may relate to the
        period of the Executive’s employment with the Company.

    

      Section 4.             Unauthorized Disclosure; Non-Competition; Non-Solicitation; Interference with Business
              Relationships; Proprietary Rights.

    

    4.1. Unauthorized Disclosure.  The Executive agrees and understands that in the Executive’s
        position with the Company, the Executive will be exposed to and will receive information relating to the confidential affairs of the Company and its Affiliates, including, without limitation, technical information, intellectual property, business
        and marketing plans, strategies, customer information, software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company and its Affiliates and other forms of
        information considered by the Company and its Affiliates to be confidential or in the nature of trade secrets (including, without limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications,
        customer and supplier lists, pricing and cost information and business and marketing plans and proposals) (collectively, the “Confidential Information”). 
        Confidential Information shall not include information that is generally known to the public or within the relevant trade or industry other than due to the Executive’s violation of this Section 4.1 or disclosure by a third party who is known by the
        Executive to owe the Company an obligation of confidentiality with respect to such information.  The Executive agrees that at all times during the Executive’s employment with the Company and thereafter, the Executive shall not disclose such
        Confidential Information, either directly or indirectly, to any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or
        instrumentality thereof (each a “Person”) without the prior written consent of the Company and shall not use or attempt to use any such information in any
        manner other than in connection with the Executive’s employment with the Company, unless required or permitted by law to disclose such information, in which case the Executive shall provide the Company with written notice of such requirement as far
        in advance of such anticipated disclosure as possible.  This confidentiality covenant has no temporal, geographical or territorial restriction.  Upon termination of the Executive’s employment with the Company, the Executive shall promptly supply to
        the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product or document which has been produced
        by, received by or otherwise submitted to the Executive during or prior to the Executive’s employment with the Company, and any copies thereof in the Executive’s (or capable of being reduced to the Executive’s) possession.  Notwithstanding the
        foregoing, nothing herein shall prevent the Executive from disclosing Confidential Information to the extent required by law.  Additionally, nothing herein shall preclude the Executive’s right to communicate, cooperate or file a complaint with any
        U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “Governmental Entity”) with respect to possible
        violations of any U.S. federal, state or local law or regulation, or otherwise make disclosures to any Governmental Entity, in each case, that are protected under the whistleblower or similar provisions of any such law or regulation; provided that in each case such communications and disclosures are consistent with applicable law.  Nothing herein shall preclude the Executive’s right to
        receive an award from a Governmental Entity for information provided under any whistleblower or similar program.  The Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade
        secret that is made in confidence to a federal, state or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law.  The Executive shall not be held criminally or civilly liable
        under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, provided that such filing is made under seal.  If the Executive files a lawsuit
        for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the trade secret to the Executive’s attorney and use the trade secret information in any related court proceeding, provided that the Executive
        files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.

    4.2. Non-Competition.  By and in consideration of the Company entering into this Agreement,
        and in further consideration of the Executive’s exposure to the Confidential Information, the Executive agrees that the Executive shall not, during the Employment Period and for a period of 12 months after the Executive’s termination of employment
        for any reason (the “Restriction Period”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the ownership,
        management, operation or control of, or be connected in any manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any Restricted
        Enterprise (as defined below); provided that in no event shall (X) ownership by the Executive of two percent or less of the outstanding securities of any
        class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as amended, standing alone, be prohibited by this Section 4.2, so long as the Executive does not have, or exercise, any rights to manage or operate the
        business of such issuer other than rights as a shareholder thereof or (Y) being employed by an entity, standing alone, be prohibited by this Section 4.2, so long as the entity has more than one discrete and readily distinguishable part of its
        business and the Executive’s duties are not at or involving the part of the entity’s business that is actively engaged in a Restricted Enterprise.  For purposes of this paragraph, “Restricted Enterprise” shall mean any Person that is engaged, directly or indirectly, in (or intends or proposes to engage in, or has been organized for the purpose of engaging in) a business which is in competition
        with a business of the Company or any of its Affiliates in any country or territory in which the Company or any of its Affiliates markets any of its services or products or has plans to begin marketing any of its services or products in such
        country or territory.  During the Restriction Period, upon request of the Company, the Executive shall notify the Company of the Executive’s then-current employment status.

    4.3. Non-Solicitation of Employees.  During the Restriction Period, the Executive shall not
        directly or indirectly hire, contact, induce or solicit (or assist any Person to hire, contact, induce or solicit) for employment any person who is, or within 12 months prior to the date of such hiring, contacting, inducing or solicitation was, an
        employee of the Company or any of its Affiliates.

    4.4. Interference with Business Relationships.  During the Restriction Period (other than
        in connection with carrying out the Executive’s responsibilities for the Company and its Affiliates), the Executive shall not directly or indirectly induce or solicit (or assist any Person to induce or solicit) any customer or client of the Company
        or its subsidiaries to terminate its relationship or otherwise cease doing business in whole or in part with the Company or its Affiliates, or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship
        between the Company or its Affiliates and any of its or their customers or clients so as to cause harm to the Company or its Affiliates.

    4.5. Extension of Restriction Period.  The Restriction Period shall be tolled for any
        period during which the Executive is in breach of any of Sections 4.2, 4.3 or 4.4 hereof.

    4.6. Proprietary Rights.  The Executive shall disclose promptly to the Company any and all
        inventions, discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by the Executive,
        either alone or in conjunction with others, during the Executive’s employment with the Company and related to the business or activities of the Company and its Affiliates (the “Developments”).  Except to the extent any rights in any Developments constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq. that are owned ab initio by the Company and/or its applicable
        Affiliate, the Executive assigns and agrees to assign all of the Executive’s right, title and interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including
        all rights or benefits therefor, including without limitation the right to sue and recover for past and future infringement.  The Executive acknowledges that any rights in any Developments constituting a work made for hire under the U.S. Copyright
        Act, 17 U.S.C § 101 et seq. are owned upon creation by the Company and/or its applicable Affiliate as the Executive’s employer.  The Executive hereby expressly and irrevocably waives any and all moral rights in the Developments including, without
        limitation, the right to attribution or anonymity in respect of authorship, the right to restrain any distortion, mutilation or other modification of any such Developments and the right to prohibit any use of any such Developments in association
        with a product, service, cause or institution that may be prejudicial to her honor or reputation.  Whenever requested to do so by the Company, the Executive shall execute any and all applications, assignments or other instruments which the Company
        shall deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company and its Affiliates therein.  These obligations shall continue beyond the
        end of the Executive’s employment with the Company with respect to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Executive while employed by the Company, and shall be binding upon the Executive’s
        employers, assigns, executors, administrators and other legal representatives.  In connection with the Executive’s execution of this Agreement, the Executive has informed the Company in writing of any interest in any inventions or intellectual
        property rights that the Executive holds as of the date hereof.  If the Company is unable for any reason, after reasonable effort, to obtain the Executive’s signature on any document needed in connection with the actions described in this Section
        4.6, the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Executive’s agent and attorney in fact to act for and on the Executive’s behalf to execute, verify and file any such
        documents and to do all other lawfully permitted acts to further the purposes of this Section 4.6 with the same legal force and effect as if executed by the Executive.

    4.7. Confidentiality of Agreement.  Other than with respect to information required or
        permitted to be disclosed by applicable law, the Parties hereto agree not to disclose the terms of this Agreement to any Person; provided that the Executive
        may disclose this Agreement and/or any of its terms to the Executive’s immediate family, financial advisors and attorneys, so long as the Executive instructs every such Person to whom the Executive makes such disclosure not to disclose the terms of
        this Agreement further.  Any time after this Agreement is filed with the SEC or any other government agency by the Company and becomes a public record, this provision shall no longer apply.

    4.8. Remedies.  The Executive agrees that any breach of the terms of this Section 4 would
        result in irreparable injury and damage to the Company for which the Company would have no adequate remedy at law; the Executive therefore also agrees that in the event of said breach or any threat of breach, the Company shall be entitled to an
        immediate injunction and restraining order to prevent such breach and/or threatened breach and/or continued breach by the Executive and/or any and all Persons acting for and/or with the Executive, without having to prove damages, in addition to any
        other remedies to which the Company may be entitled at law or in equity, including, without limitation, the obligation of the Executive to return any portion of the Severance Amount paid by the Company to the Executive.  The terms of this paragraph
        shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including, without limitation, the recovery of damages from the Executive.  The Executive and the Company further agree that the
        provisions of the covenants contained in this Section 4 are reasonable and necessary to protect the businesses of the Company and its Affiliates because of the Executive’s access to Confidential Information and the Executive’s material
        participation in the operation of such businesses.

    Section 5.             Representations.  The Executive represents and warrants that
        (a) the Executive is not subject to any contract, arrangement, policy or understanding, or to any statute, governmental rule or regulation, that in any way limits the Executive’s ability to enter into and fully perform the Executive’s obligations
        under this Agreement and (b) the Executive is not otherwise unable to enter into and fully perform the Executive’s obligations under this Agreement.  In the event of a breach of any representation in this Section 5, the Company may terminate this
        Agreement and the Executive’s employment with the Company without any liability to the Executive and the Executive shall indemnify the Company for any liability it may incur as a result of any such breach.

    Section 6.             Non-Disparagement.  From and after the Effective Date and following termination of the
        Executive’s employment with the Company, the Executive agrees not to make any statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory
        of the Company, any of its subsidiaries, Affiliates, employees, officers, directors or stockholders. Similarly, from and after the Effective Date and following termination of the Executive’s employment with the Company, the Company agrees to
        instruct each director and executive officer of the Company not to make any statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory
        of the Executive.

    Section 7.             Taxes; Clawbacks.

    7.1. Withholding.  All amounts paid to the Executive under this Agreement during or
        following the Employment Period shall be subject to withholding and other employment taxes imposed by applicable law.  The Executive shall be solely responsible for the payment of all taxes imposed on the Executive relating to the payment or
        provision of any amounts or benefits hereunder.

    7.2. Section 280G.

    (a) If (i) the aggregate of all amounts and benefits due to the Executive under this Agreement or under any other Company arrangement would, if
        received by the Executive in full and valued under Section 280G of the Code, constitute “parachute payments” as defined in and under Section 280G of the Code (collectively, “280G Benefits”), and if (ii) such aggregate would, if reduced by all federal, state and local taxes applicable thereto, including the excise tax imposed pursuant to Section 4999 of the Code, be less than the amount the
        Executive would receive, after all taxes, if the Executive received aggregate 280G Benefits equal (as valued under Section 280G of the Code) to only three times the Executive’s “base amount” as defined in and under Section 280G of the Code, less
        $1.00, then (iii) such 280G Benefits as the Executive shall select shall (to the extent that the reduction of such 280G Benefits can achieve the intended result and such 280G Benefits are not subject to Section 409A of the Code) be reduced or
        eliminated to the extent necessary so that the aggregate 280G Benefits received by the Executive will not constitute parachute payments.  Notwithstanding the foregoing, if any 280G Benefits are subject to Section 409A of the Code or if the
        Executive fails to select an order under the preceding sentence, any such reduction shall occur in the following order: (i) by eliminating the acceleration of vesting of any stock options for which the exercise price exceeds the fair market value
        (and if there is more than one option award so outstanding, then the acceleration of the vesting of the most “under water” option shall be reduced first, and so-on); (ii) by reducing any cash payments not subject to Section 409A of the Code; (iii)
        by reducing any benefit continuation payments (and if there be more than one such payment, by reducing the payments in reverse order, with the payments made the earliest being reduced first); (iv), by reducing any cash payments that are subject to
        Section 409A of the Code (and if there be more than one such payment, by reducing the payments in reverse order, with the payments made the earliest being reduced first); (v) by reducing the payments of any restricted stock, restricted stock units,
        performance awards or similar equity-based awards that have been awarded to the Executive by the Company that are subject to performance-based vesting (and if there be more than one such award held by the Executive, by reducing the awards in the
        reverse order of the date of their award, with the most-recently awarded reduced first and the oldest award reduced last); (vi) by reducing the payments of any restricted stock, restricted stock units, performance awards or similar equity-based
        awards that have been awarded to the Executive by the Company that are subject to time-based vesting (and if there be more than one such award held by Executive, by reducing the awards in the reverse order of the date of their award, with the
        most-recently awarded reduced first and the oldest award reduced last); and (vii) by reducing the acceleration of vesting of any stock options that are not described in (i), above.

    (b) The determinations with respect to this Section 7.2 shall be made by an independent auditor (the “Auditor”) paid by the Company.  The Auditor shall be the Company’s regular independent auditor unless the Executive reasonably objects to the use of that firm, in which event the Auditor will be a
        nationally recognized United States public accounting firm chosen by the Parties.

    (c) It is possible that after the determinations and selections made pursuant to this Section 7.2, the Executive will receive 280G Benefits that
        are, in the aggregate, either more or less than the amount provided under this Section 7.2 (hereafter referred to as an “Excess Payment” or “Underpayment,” respectively).  If it is established, pursuant to a final determination of a court or an
        Internal Revenue Service proceeding that has been finally and conclusively resolved, that an Excess Payment has been made, then the Executive shall promptly pay an amount equal to the Excess Payment to the Company, together with interest on such
        amount at the applicable federal rate (as defined in and under Section 1274(d) of the Code) from the date of the Executive’s receipt of such Excess Payment until the date of such payment.  In the event that it is determined (i) by a court or (ii)
        by the Auditor upon request by a Party, that an Underpayment has occurred, the Company shall promptly pay an amount equal to the Underpayment to the Executive, together with interest on such amount at the applicable federal rate from the date such
        amount would have been paid to the Executive had the provisions of this Section 7.2 not been applied until the date of such payment.

    (d) Notwithstanding the foregoing, if it appears that any amount or benefit that is to be paid to the Executive under this Agreement or any other
        plan, program, agreement, or arrangement of the Company or any of its Affiliates may constitute a “parachute payment” under Section 280G(b)(2) of the Code, the Company shall use its best reasonable efforts to obtain shareholder approval of such
        payments for purposes of Section 280G(b)(5) of the Code.

    7.3. Clawbacks.  If any law, rule or regulation applicable to the Company or its Affiliates
        (including any rule or requirement of any nationally recognized stock exchange on which the stock of the Company or its Affiliates has been listed), or any policy of the Company or its Affiliates reasonably designed to comply therewith, requires
        the forfeiture or recoupment of any amount paid or payable to the Executive hereunder (or under any other agreement between the Executive and the Company or its Affiliates or under any plan in which the Executive participates), the Executive hereby
        consents to such forfeiture or recoupment, in each case in the time and manner determined by the Company in its reasonable good faith discretion.  Furthermore, if the Executive engages in any act of embezzlement, fraud or dishonesty involving the
        Company or its Affiliates which results in a financial loss to the Company or its Affiliates, the Company shall be entitled to recoup an amount from the Executive determined by the Company in its reasonable discretion to be commensurate with such
        financial loss.

    Section 8.             Miscellaneous.

    8.1. Indemnification & Insurance.  The Executive shall continue to be covered under
        that certain Indemnification Agreement between the Executive and Parent dated April 24, 2019. The Executive shall be covered under any directors’ and officers’ insurance that the Company maintains for its directors and other officers in the same
        manner and on the same basis as the Company’s other directors and other senior officers.

    8.2. Amendments and Waivers.  This Agreement and any of the provisions hereof may be
        amended, waived (either generally or in a particular instance and either retroactively or prospectively), modified or supplemented, in whole or in part, only by written agreement signed by the Parties hereto; provided that the observance of any provision of this Agreement may be waived in writing by the Party that will lose the benefit of such provision as a result of such waiver.  The
        waiver by any Party hereto of a breach of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach, except as otherwise explicitly provided
        for in such waiver.  Except as otherwise expressly provided herein, no failure on the part of any Party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity,
        shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such Party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.

    8.3. Assignment; No Third-Party Beneficiaries.  This Agreement, and the Executive’s rights
        and obligations hereunder, may not be assigned by the Executive, and any purported assignment by the Executive in violation hereof shall be null and void.  Nothing in this Agreement shall confer upon any Person not a party to this Agreement, or the
        legal representatives of such Person, any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement, except the personal representative of the deceased Executive may enforce the provisions hereof applicable in the
        event of the death of the Executive.  The Company is authorized to assign this Agreement and its rights and obligations hereunder without the consent of the Executive in the event that the Company hereafter affects a reorganization, consolidates
        with or merges into any other Person or entity, or transfers all or substantially all of its properties or assets to any other Person or entity.

    8.4. Notices.  Unless otherwise provided herein, all notices, requests, demands, claims and
        other communications provided for under the terms of this Agreement shall be in writing.  Any notice, request, demand, claim or other communication hereunder shall be sent by (i) personal delivery (including receipted courier service) or overnight
        delivery service, with confirmation of receipt, (ii) e-mail, (iii) facsimile during normal business hours, with confirmation of receipt, to the number indicated, (iv) reputable commercial overnight delivery service courier, with confirmation of
        receipt or (v) registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient as set forth below:

    If to the Company:

    

    

    Emerald Expositions, LLC

    31910 Del Obispo St., Suite 200

    San Juan Capistrano, CA  92675

    Attention:  Chairman of the Board and General Counsel

     

    

    with a copy to:

    

    

    Fried, Frank, Harris, Shriver & Jacobson LLP

    One New York Plaza

    New York, NY  10004

    Attention:  Jeffrey Ross, Esq.

    Facsimile:  212-859-4000

    

    

    
      
        	

              	If to the Executive:	
                At the Executive’s principal office at the Company (during the Employment Period), and at all times to the Executive’s principal residence as reflected in the
                    records of the Company.  If by e-mail, to the Executive’s Company-supplied e-mail address.

              

      

    

    

    

    All such notices, requests, consents and other communications shall be deemed to have been given when received.  Either
        Party may change its facsimile number or its address to which notices, requests, demands, claims and other communications hereunder are to be delivered by giving the other parties hereto notice in the manner then set forth.

    

    

    8.5. Governing Law.  This Agreement shall be construed and enforced in accordance with, and
        the rights and obligations of the parties hereto shall be governed by, the laws of the State of New York without giving effect to the conflicts of law principles thereof.

    8.6. Jurisdiction; Waiver of Jury Trial.  The Executive agrees that jurisdiction and venue for any action arising from or relating to this Agreement or
        the relationship between the parties, including but not limited to matters concerning validity, construction, performance, or enforcement, shall be exclusively in the federal and state courts of the State of New York located in New York County
        (collectively, the “Selected Courts”) (provided, that a final judgment in any such action shall be conclusive and enforced in other jurisdictions) and
        further agree that service of process may be made in any matter permitted by law.  The Executive irrevocably waives and agrees not to assert (i) any objection which it may ever have to the laying of venue of any action or proceeding arising out of
        this Agreement or the transactions contemplated hereby in the Selected Courts, and (ii) any claim that any such action brought in any such court has been brought in an inconvenient forum.  This Section 8.6 is intended to fix the location of
        potential litigation between the parties and does not create any causes of action or waive any defenses or immunities to suit.  EACH PARTY WAIVES ANY RIGHT TO A TRIAL BY JURY, TO THE EXTENT LAWFUL, AND AGREES THAT ANY OF THEM MAY FILE A COPY OF
        THIS PARAGRAPH WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE ITS RIGHT TO TRIAL BY JURY IN ANY LITIGATION WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR THE
        CONTEMPLATED TRANSACTIONS.

    8.7. Severability.  Whenever possible, each provision or portion of any provision of this
        Agreement, including those contained in Section 4 hereof, will be interpreted in such manner as to be effective and valid under applicable law but the invalidity or unenforceability of any provision or portion of any provision of this Agreement in
        any jurisdiction shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision or portion of any provision, in any other
        jurisdiction.  In addition, should a court or arbitrator determine that any provision or portion of any provision of this Agreement, including those contained in Section 4 hereof, is not reasonable or valid, either in period of time, geographical
        area, or otherwise, the Parties hereto agree that such provision should be interpreted and enforced to the maximum extent which such court or arbitrator deems reasonable or valid.

    8.8. Entire Agreement.  From and after the Effective Date, this Agreement constitutes the
        entire agreement between the Parties hereto, and supersedes all prior representations, agreements and understandings (including any prior course of dealings), both written and oral, between the Parties hereto with respect to the subject matter
        hereof.

    8.9. Counterparts.  This Agreement may be executed by .pdf or facsimile signatures in any
        number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same instrument.

    8.10. Binding Effect.  This Agreement shall inure to the benefit of, and be binding on, the
        successors and assigns of each of the Parties, including, without limitation, the Executive’s heirs and the personal representatives of the Executive’s estate and any successor to all or substantially all of the business and/or assets of the
        Company.

    8.11. General Interpretive Principles.  The name assigned this Agreement and headings of the
        sections, paragraphs, subparagraphs, clauses and subclauses of this Agreement are for convenience of reference only and shall not in any way affect the meaning or interpretation of any of the provisions hereof.  Words of inclusion shall not be
        construed as terms of limitation herein, so that references to “include,” “includes” and “including” shall not be limiting and shall be regarded as references to non-exclusive and non-characterizing illustrations.  Any reference to a Section of the
        Code shall be deemed to include any successor to such Section.

    8.12. Affiliates.  For purposes of this Agreement, the term “Affiliates” means any person or entity Controlling, Controlled
        by, or Under Common Control with the Company.  The term “Control,” including the correlative terms “Controlling,” “Controlled By,” and “Under

            Common Control with” means possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities of any company or other ownership interest, by contract
        or otherwise) of a person or entity.

    [signature page follows]

    
      
        

    

    IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

    
      
        	
                 

              	
                EMERALD EXPOSITIONS, LLC

              	 
	 	 	 
	 	 	 
	
                 

              	
                By:

              	
                /s/ David Gosling

              	 
	
                 

              	
                Name:

              	
                David Gosling

              	 
	
                 

              	
                Title:

              	
                SVP, General Counsel and Secretary

              	 

      

      

      

      

      

      

      

      
        	
                 

              	
                EMERALD EXPOSITIONS EVENTS, INC.

              	 
	 	(solely for purposes of Section 2.3 of this Agreement)	 
	 	 	 
	 	 	 
	
                 

              	
                By:

              	
                /s/ David Gosling

              	 
	
                 

              	
                Name:

              	
                David Gosling

              	 
	
                 

              	
                Title:

              	
                SVP, General Counsel and Secretary

              	 

      

      

      

      

      

      

      

      
        	 	EXECUTIVE	 
	 	 	 
	
                 

              	
                /s/ Sally Shankland

              	 
	 	
                Sally Shankland

              	 

         

      

    

  

  
    
      
        

    

    Exhibit A

    Form of Performance
            Based Share Award Agreement

    
      
        

    

    Exhibit B

    You should consult with an attorney before signing this release of claims.

    Release

    1. In consideration of the payments and benefits to be made under the Employment Agreement, dated as of May 12, 2019 (the “Employment Agreement”), by and between Sally Shankland (the “Executive”) and Emerald Expositions, LLC, (the “Company”) (each of the Executive and the Company, a “Party” and
        collectively, the “Parties”), and solely for the purpose of Section 2.3 of the Employment Agreement, Emerald Expositions Events, Inc., (“Parent”), the sufficiency of which the Executive acknowledges, the Executive, with
          the intention of binding the Executive and the Executive’s heirs,
          executors, administrators and assigns, does hereby release, remise, acquit and forever discharge the Company and each of its subsidiaries and Affiliates (the “Company

            Affiliated Group”), their present and former officers, directors, executives, shareholders, insurers, agents, attorneys, employees and employee benefit
          plans (and the fiduciaries thereof), and the successors, predecessors and assigns of each of the foregoing (collectively, the “Company Released Parties”), of and from any and all claims, actions, causes of action, complaints, charges, demands, rights, damages, debts, sums of money, accounts, financial obligations, suits,
          expenses, attorneys’ fees and liabilities of whatever kind or nature in law, equity or otherwise, whether accrued, absolute, contingent, unliquidated or otherwise and whether now known or unknown, suspected or unsuspected, which the Executive,
          individually or as a member of a class, now has, owns or holds, or has at any time heretofore had, owned or held, arising on or prior to the date hereof, against any Company Released Party that arises out of, or relates to, the Employment
          Agreement, the Executive’s employment with the Company or any of its subsidiaries and Affiliates, or any termination of such employment, including claims (i) for severance, unpaid wages, salary or incentive payments, (ii) for breach of contract,
          wrongful discharge, impairment of economic opportunity, defamation, intentional infliction of emotional harm or other tort, (iii) for any violation of applicable state and local labor and employment laws (including, without limitation, all laws
          concerning unlawful and unfair labor and employment practices) and (iv) for employment discrimination under any applicable federal, state or local statute, provision, order or regulation, and including, without limitation, any claim under Title VII of the Civil Rights Act of 1964 (“Title VII”), the Civil Rights Act of 1988, the Fair Labor Standards Act, the
          Americans with Disabilities Act (“ADA”), the Employee Retirement Income
          Security Act of 1974, as amended (“ERISA”), the Age Discrimination in
          Employment Act (“ADEA”), the New York Labor Code (specifically
          including the New York Retaliatory Action by Employers Law, the New York State Worker Adjustment and Retraining Notification Act, the New York Nondiscrimination for Legal Actions Law and Article 6 of the New York Labor Law (which regulates the
          payment of wages and prohibits employers from discriminating in wages based on sex)), Section 125 of the New York Workers’ Compensation Law, Article 4 of the New York Civil Rights Law, and any similar or analogous state statute, excepting only:

    
      	
              A.

            	
              rights of the Executive arising under, or preserved by, this Release or Section 3 of the Employment Agreement;

            

    

    
      	
              B.

            	
              the right of the Executive to receive COBRA continuation coverage in accordance with applicable law;

            

    

    
      	
              C.

            	
              claims for benefits under any health, disability, retirement, life insurance or other, similar employee
                  benefit plan (within the meaning of Section 3(3) of ERISA) of the Company Affiliated Group;

            

    

    
      	
              D.

            	
              rights to indemnification the Executive has or may have under the by-laws or certificate of incorporation of
                  any member of the Company Affiliated Group or as an insured under any director’s and officer’s liability insurance policy now or previously in force; and

            

    

    
      	
              E.

            	
              rights granted to the Executive
                    during the Executive’s employment related to the purchase and/or grant of equity of Emerald Expositions Events, Inc.

            

    

    2. The Executive acknowledges and agrees that this Release is not to be construed in any way as an admission of any liability whatsoever by any Company Released Party, any such
        liability being expressly denied.

    3. This Release applies to any relief no matter how called, including, without limitation, wages, back pay, front pay, compensatory damages, liquidated damages, punitive damages,
        damages for pain or suffering, costs, and attorneys’ fees and expenses.

    4. The Executive specifically acknowledges that the Executive’s acceptance of the terms of this Release is, among other things, a specific waiver of the Executive’s rights,
          claims and causes of action under Title VII, ADEA, ADA and any state or local law or regulation in respect of discrimination of any kind; provided, however, that nothing herein shall be deemed, nor does anything contained herein purport, to be a waiver of any right or claim or cause of action which by law the Executive is not permitted to waive.

    5. The Executive acknowledges that the Executive has been given a period of twenty-one (21) days to consider whether to execute this Release.  If the Executive accepts the terms hereof and executes this Release, the Executive may
          thereafter, for a period of seven (7) days following (and not including) the date of execution, revoke this Release.  Any revocation within this period must be submitted, in writing, to Eileen Deady, VP, HR, Emerald Expositions, LLC, 100
          Broadway, 14th Floor, New York, NY 10005, and must state: “I hereby revoke my acceptance of the Release of Claims.”  The revocation must be either: (a)
          personally delivered to Eileen Deady within 7 calendar days after the day Executive signs the Release; (b) mailed to Eileen Deady at the address specified above by First Class United States mail and postmarked within 7 calendar days after the day
          Executive signs the Release; or (c) delivered to Eileen Deady at the address specified above through a reputable overnight delivery service with documented evidence that it was sent within 7 calendar days after the day Executive signed the
          Release.  If no such revocation occurs, this Release shall become irrevocable in its entirety, and binding and enforceable against the Executive, on the day next following the day on which the foregoing seven-day period has elapsed.  If such a
          revocation occurs, the Executive shall irrevocably forfeit any right to payment of the Severance Amount or provision of the Medical Benefit Continuation (as each is defined in the Employment Agreement), but the remainder of the Employment
          Agreement shall continue in full force.

    6. The Executive acknowledges and agrees that the Executive has not, with respect to any transaction or state of facts existing prior to the date hereof, filed or caused to be
        filed, and is not presently a party to, any complaints, charges or lawsuits against any Company Released Party with any governmental agency, court or tribunal.  The Executive agrees to immediately withdraw or dismiss any complaints, charges or lawsuits that she has filed or caused to be filed, or to which she is a party,
        against any Company Released Party.  The Executive agrees not to file or maintain any other complaint, charge or lawsuit against any Company Released Party arising out of the matters covered by this Release and agrees not to participate in,
        encourage the pursuit of any claims, or accept payment from any litigation or threatened litigation against any Company Released Party, unless compelled to testify pursuant to subpoena or order of a court of competent jurisdiction.

    7. THE EXECUTIVE ACKNOWLEDGES THAT THE EXECUTIVE HAS BEEN ADVISED TO SEEK, AND HAS HAD THE OPPORTUNITY TO SEEK, THE ADVICE AND ASSISTANCE OF AN ATTORNEY WITH REGARD TO THIS
        RELEASE, AND HAS BEEN GIVEN A SUFFICIENT PERIOD WITHIN WHICH TO CONSIDER THIS RELEASE.

    8. The Executive acknowledges that this Release relates only to claims that exist as of the date of this Release.

    9. The Executive acknowledges that the severance payments and benefits the Executive is receiving in connection with this Release and the Executive’s obligations under this Release
        are in addition to anything of value to which the Executive is entitled from the Company.

    10. Each provision hereof is severable from this Release, and if one or more provisions hereof are declared invalid, the remaining provisions shall nevertheless remain in full force
        and effect.  If any provision of this Release is so broad, in scope, or duration or otherwise, as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable.

    11. This Release constitutes the complete agreement of the Parties in respect of the subject matter hereof and shall supersede all prior agreements between the Parties in respect of
        the subject matter hereof except to the extent set forth herein.  For the avoidance of doubt, however, nothing in this Release shall constitute a waiver of any Company
          Released Party’s right to enforce any obligations of the Executive under the Employment Agreement that survive the Employment Agreement’s termination, including without limitation, any non-competition covenant, non-solicitation covenant or any
          other restrictive covenants contained therein.

    12. The failure to enforce at any time any of the provisions of this Release or to require at any time performance by another party of any of the provisions hereof shall in no way
        be construed to be a waiver of such provisions or to affect the validity of this Release, or any part hereof, or the right of any party thereafter to enforce each and every such provision in accordance with the terms of this Release.

    13. This Release may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. 
        Signatures delivered by facsimile, email or pdf shall be deemed effective for all purposes.

    14. This Release shall be binding upon any and all successors and assigns of the Executive and the Company.

    15. Except for issues or matters as to which federal law is applicable, this Release shall be governed by and construed and enforced in accordance with the laws of the State of New
        York without giving effect to the conflicts of law principles thereof.

    16. Employee further affirms that she has timely been paid or has received all compensation, wages, bonuses, commissions and benefits to which she may be entitled and that no other leave (paid or unpaid), compensation, wages, bonuses, commissions or benefits are due to her except as follows:

    
      	
               

            	

            	
               

            
	
               

            	
               

            	
               

            
	 	 	 

    

    

    [signature page follows]

    
      
        

    

    IN WITNESS WHEREOF, this Release has been signed by or on behalf of each of the Parties, all as of ____________________.

    

    

    
      
        
          
            
              
                

                

                
                  	 

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                          EMERALD EXPOSITIONS, LLC

                        
	 	 	 	 
	
                           

                        	
                           

                        	
                           

                        	
                           

                        
	
                           

                        	
                           

                        	
                           

                        	
                           

                        	 

                        	 By: 	
                          
                            

                            

                          

                        
	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                          Name: 

                            

                        
	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                           

                        	
                          Title:  

                            

                        

                

                

                

                 

                

            

            
              
                	 

                      	
                         

                      	
                         

                      	
                         

                      	
                         

                      	
                         

                        EXECUTIVE

                      
	 	 	 	 	 	

                      	

                      
	
                         

                      	
                         

                      	
                         

                      	
                         

                      
	 	 	 	

                      
	 	 	 	
                        Sally Shankland

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]